文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Cancer Stem Cells in Tumours of the Central Nervous System in Children: A Comprehensive Review.

作者信息

Han Yi-Peng, Lin Hou-Wei, Li Hao

机构信息

Department of Neurosurgery, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China.

Department of Paediatric Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.

出版信息

Cancers (Basel). 2023 Jun 11;15(12):3154. doi: 10.3390/cancers15123154.


DOI:10.3390/cancers15123154
PMID:37370764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10295943/
Abstract

Cancer stem cells (CSCs) are a subgroup of cells found in various kinds of tumours with stem cell characteristics, such as self-renewal, induced differentiation, and tumourigenicity. The existence of CSCs is regarded as a major source of tumour recurrence, metastasis, and resistance to conventional chemotherapy and radiation treatment. Tumours of the central nervous system (CNS) are the most common solid tumours in children, which have many different types including highly malignant embryonal tumours and midline gliomas, and low-grade gliomas with favourable prognoses. Stem cells from the CNS tumours have been largely found and reported by researchers in the last decade and their roles in tumour biology have been deeply studied. However, the cross-talk of CSCs among different CNS tumour types and their clinical impacts have been rarely discussed. This article comprehensively reviews the achievements in research on CSCs in paediatric CNS tumours. Biological functions, diagnostic values, and therapeutic perspectives are reviewed in detail. Further investigations into CSCs are warranted to improve the clinical practice in treating children with CNS tumours.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad61/10295943/1e564d7f76a4/cancers-15-03154-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad61/10295943/1e564d7f76a4/cancers-15-03154-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad61/10295943/1e564d7f76a4/cancers-15-03154-g001.jpg

相似文献

[1]
Cancer Stem Cells in Tumours of the Central Nervous System in Children: A Comprehensive Review.

Cancers (Basel). 2023-6-11

[2]
Cancer stem cells in the mammalian central nervous system.

Cell Prolif. 2005-12

[3]
The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.

Dan Med J. 2014-10

[4]
Institutional experience of paediatric high-grade central nervous system tumours: an analysis of 74 patients and review of the literature.

Contemp Oncol (Pozn). 2012

[5]
Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.

Eur J Med Genet. 2023-1

[6]
Understanding of tumourigenesis in canine mammary tumours based on cancer stem cell research.

Vet J. 2020-11

[7]
Italian cancer figures, report 2012: Cancer in children and adolescents.

Epidemiol Prev. 2013

[8]
Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells.

Onco Targets Ther. 2020-1-16

[9]
Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.

Clin Epigenetics. 2023-3-9

[10]
Central nervous system tumours in children in Ibadan, Nigeria: a histopathologic study.

Pan Afr Med J. 2016-5-9

引用本文的文献

[1]
How is rosette formation in brain tumours linked with cerebrospinal fluid spread?

Brain Tumor Pathol. 2025-8-12

[2]
Leveraging Neural Crest-Derived Tumors to Identify NF1 Cancer Stem Cell Signatures.

Cancers (Basel). 2024-10-29

本文引用的文献

[1]
Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.

J Clin Invest. 2023-3-1

[2]
Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors' Cancer Stem Cells: Current Knowledge and Future Perspectives.

Pharmaceutics. 2023-2-2

[3]
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908.

Neuro Oncol. 2023-8-3

[4]
CAR T cells: engineered immune cells to treat brain cancers and beyond.

Mol Cancer. 2023-1-31

[5]
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.

J Clin Oncol. 2023-4-10

[6]
Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling.

Acta Neuropathol Commun. 2022-8-19

[7]
Extent of Tumor Resection and Survival in Pediatric Patients With High-Grade Gliomas: A Systematic Review and Meta-analysis.

JAMA Netw Open. 2022-8-1

[8]
Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma.

Nat Commun. 2022-7-8

[9]
A paediatric dysembryoplastic neuroepithelial tumour (DNET) with deregulated stem cell markers: a case report.

Transl Pediatr. 2022-6

[10]
The H3K27M mutation alters stem cell growth, epigenetic regulation, and differentiation potential.

BMC Biol. 2022-5-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索